Bone Regeneration Material Market

Bone Regeneration Material Market Size (2023 to 2028)

As per our analysis report, the Global Bone Regeneration Material Market is expected to reach USD 3.8 billion by 2028 from USD 2.58 billion in 2023, growing at a compound annual growth rate (CAGR) of 4.5% during the forecast period.

Bone regeneration materials are extensively used to treat bone disorders and play a crucial in the quick recovery of bone fractures.

MARKET DRIVERS:

The rising cases of orthopedic conditions and degenerative bone disorders are the primary factors for the growth of the global bone regeneration material market. Also, the exponential growth in the geriatric population across the world, which is registering several bone-related diseases, is another factor driving the demand for this business. In addition, with the recent changes in consumer lifestyle, the number of cases of obesity and unhealthy diet are at a surge, leading to ailments like osteoporosis. People's increasing purchasing power, coupled with their increasing awareness about non-invasive procedures, is boosting the bone regeneration materials market. Also, the supportive government norms for the quick approval of regenerative medicines and improved innovation spending by the companies in the healthcare and pharmaceutical industry further promote the growth rate of the global market.

Besides, the recent advances in technology have transformed the shape of medical and biotechnology sectors in terms of effective and affordable treatments, which is supporting the bone regeneration materials market. With the increasing globalization, the healthcare sector has exploded, and medical tourism has become a new norm for patients. Further, the trend of customized treatment and tailored medicines according to consumer preferences is impacting the market positively for bone regeneration material. In addition, the extensive research activities for the development of biomaterials to be used in the production of these materials will favor the market boom in the foreseen period. Moreover, the continuous developments in medical technology, artificial intelligence, and robotics, along with partnerships among healthcare facilities and research centers, are touted to create immense growth opportunities for the global bone regeneration material market.

MARKET RESTRAINTS:

The major constraint to the bone regeneration material market is the high initial investments for the development of the products and subsequent pricing for the patients. Although the governments are supporting the development of regenerative medicines, the stringent conditions related to safety aspects and other complexities involved are acting as a challenge for the rapid movement in this business. In addition, the lack of proper insurance coverage for these treatments is limiting a certain portion of the patient population from looking for alternative, cost-effective procedures. Also, the effects caused by these regeneration materials, in the long run, are still uncertain due to the shortage of supportive clinical and research trials, which is a concerning area for the growth of the bone regeneration material market. Besides, the issues related to compatibility, the complexity involved in the surgical procedures, the absence of skilled practitioners in most parts of the world, missing standardization and extended timeframe for the development of new products can pose a serious threat to the bone regeneration materials business in the coming years.

Impact of COVID-19 on the bone regeneration material market:

The COVID-19 pandemic had an initial negative impact on the global bone regeneration material market. The lockdown restrictions resulted in supply chain disruptions, leading to the shortage of raw materials and delay in the production of the devices used for the treatments. The shutdown of several companies led to the halt of research and development activities and a pause in the approval of several new products. In addition, the decreased budget and expenditures have affected the studies related to bone regeneration material applications. Also, the temporary shutdowns and contactless conditions constrained the clinical trials, recruitments and direct patient interactions. Besides, there was a huge delay in approvals for several new applications and trials using bone regeneration material due to the focus on controlling the spread of the pandemic. On the other hand, the COVID-19 pandemic improved emphasis on the need for advanced healthcare infrastructure and increased investments in innovations, which will act as an opportunity for the bone regeneration materials market in the days ahead. Moreover, the increase in remote consulting and telemedicine led to new ways of conducting trials and development activities.

REPORT COVERAGE:

This research report on the global bone regeneration material market has been segmented and sub-segmented into type, application and region.

Bone Regeneration Material Market – By Type:

• Synthetic Materials
• Xenogene Bone Materials
• Partially Synthetic Materials
• Others

Xenogene bone materials recorded the majority share in the global bone regeneration materials market due to the increased use of these materials in several bone disorders and fracture treatments. The Xenogene materials are typically extracted from animal sources and are pivotal in bone grafting substitutes. In addition, the applications of bone grafting substitutes in the void filling, spine fusion, treatment of bone ailments and fracture unifications are supporting the business growth of Xenogene bone materials worldwide. Similarly, other materials like polymers, ceramics and other biodegradable products are gaining traction the making of bone regenerative materials.

Bone Regeneration Material Market – By Application:

• Orthopaedic Surgery
• Dental Surgery
• Bone Trauma

Orthopaedic surgeries accounted for a prominent share in the world market for bone regeneration materials due the spike in the number of road accidents and fracture cases. The advantages of orthopedic surgeries in the bone healing process and replacement of bone joints will benefit this segment's growth in the market. In addition, procedures like implants and jaw improvements are supposed to boost the dental surgeries segment. Besides, the bone trauma market is likely to witness strong growth in the anticipated period owing to the surge in the elderly population and treatments like osteoporosis across the globe.

Bone Regeneration Material Market - By Region:

• North America
• Europe
• Asia Pacific
• Latin America
• The Middle East and Africa

North America registered the majority share of the global bone regeneration material market. The USA and Canada are the leading areas in North America. Being home to some of the leading companies, North America offers huge innovation opportunities for the growth of bone regenerative materials. The advanced pharmaceutical sector and the increase in the number of patients with bone diseases, joint ailments, and vehicle accidents are fuelling the growth of the North American market. The USA accounts for the dominant share in North America due to the increasing investments by companies in research and development activities. In addition, the number of bone grafting treatments to replace defective bones is supporting the regional market.

The Asia Pacific is anticipated to expand with a considerable growth rate in this market over the forecast period due to the increasing population with different kinds of bone disorders. China is the leading market in this region because of the continuous developments in the healthcare industry and investments in innovative technologies. In addition, the rising awareness about non-invasive surgical treatments is encouraging more patients to look towards this region. Moreover, the spike in bone-related damages among all demographics is further estimated to drive market growth in the APAC nations.

Europe is also a significant market for bone regeneration material owing to the advanced medical facilities and customized treatment options. The growing adaptation of bone regeneration material in osteoporosis treatment and favorable insurance policies in some countries like the United Kingdom, Germany, etc., is boosting the European market growth.

Latin America has a relatively smaller presence in the global bone regeneration material market compared to the above-mentioned regions. However, the increasing demand for advanced treatments, established regulations, and growing investments in research activities will create a huge opportunity in the Latin American nations in the days ahead.

The Middle East and Africa region have also been smaller players in the bone regeneration material market. Recently, some of the nations like South Africa, Saudi Arabia and the United Arab Emirates started focusing on improving the traditional healthcare infrastructure, thereby improving the research in advanced therapeutics, which can increase the market share of this region in the future.

KEY MARKET PLAYERS:

Johnson & Johnson, Medtronic PLC, Integra Lifesciences Holdings Corporation, Geistlich Pharma AG, NovaBone, Citagenix, Sigma Graft, Stryker Corporation, Smith Nephew, SeaSpine, Zimmer Biomet, Baxter International, Orthofix Holdings, Ethoss Regeneration, Septodont, Kerr Restoratives, J Morita USA, B&B Dental, Arthrex Inc., DePuy Synthes Inc., BMT Group, Exactech Inc., RTI Surgical, Allosaurus, Osstem Implant, and Institut Straumann AG.

RECENT MARKET DEVELOPMENTS:

• In September 2023, Botiss Biomaterials GmbH introduced three dental biomaterials to expand its presence in the global markets. NOVAMag membranes were made of resorbable magnesium. Secondly, Cerabone Plus was a combination of hyaluronate and bovine bone to support bone regeneration in the dental industry. Finally, to enhance oral treatments and optimize levels of vitamin D, the company developed a quick solution named botissCARE.
• In December 2022, Stryker introduced its Citrefix Suture Anchor System to promote bone regeneration and normal healing in foot surgeries. The product was developed from an elastomeric material called Citregen that allows controlled resorption in bones.
• In August 2022, Ossio introduced its OSSIOfiber 4.75 Suture Anchor to improve the orthopedic surgery process and offer a biocompatible solution without affecting the patient’s bone.